Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis

A Kurtaran; M Raderer; C Müller; R Prokesch; K Kaserer; K Eibenberger; K Koperna; B Niederle; I Virgolini

Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis

J Nucl Med. 1997 Jun;38(6):880-1.

Authors

A Kurtaran¹, M Raderer, C Müller, R Prokesch, K Kaserer, K Eibenberger, K Koperna, B Niederle, I Virgolini

Affiliation

¹ Department of Nuclear Medicine, University of Vienna, Austria.

PMID: 9189133

Abstract

We report a case of a hepatic carcinoid metastasis mimicking a hemangioma on ultrasound and on CT. Indium-111-DTPA-D-Phe-1-octreotide (111In-OCT) and 123I-vasoactive intestinal peptide (123I-VIP) receptor images suggested a carcinoid metastasis of the liver. The final diagnosis was established histopathologically. The differential diagnosis of liver lesions is discussed.

Publication types

Case Reports

MeSH terms

Carcinoid Tumor / diagnosis
Carcinoid Tumor / diagnostic imaging*
Carcinoid Tumor / secondary*
Diagnosis, Differential
Female
Hemangioma / diagnosis
Hemangioma / diagnostic imaging
Humans
Indium Radioisotopes*
Iodine Radioisotopes*
Liver Neoplasms / diagnosis
Liver Neoplasms / diagnostic imaging*
Liver Neoplasms / secondary*
Middle Aged
Octreotide / analogs & derivatives*
Pentetic Acid / analogs & derivatives*
Radiopharmaceuticals
Receptors, Somatostatin / analysis*
Receptors, Vasoactive Intestinal Peptide / analysis*
Tomography, Emission-Computed, Single-Photon

Substances

Indium Radioisotopes
Iodine Radioisotopes
Radiopharmaceuticals
Receptors, Somatostatin
Receptors, Vasoactive Intestinal Peptide
SDZ 215-811
Pentetic Acid
Octreotide